Water at JPM2024.

Keep a close eye on Nvidia's $NVDA biological platform 🧫, featuring $RXRX, LOWE, Terray Therapeutics , and more. By modeling human cells akin to GPT datasets, we're unlocking vast potential in drug discovery. A groundbreaking leap forward! #JPM2024
🚀🧬

My summary of the last #JPM2024 #JPM24 day so far.

$CYTK
$AUTL
$IPSC

Assalam o Alaikum 🍁
Good night 🌼
Sleep well ❤️

#bbtvi #BycottMaldives #uksnow #SPM2023 #Devara #BillsMafia #GoodNightYouAll #GoodNightTwitterWorld #JPM2024 #Japan #πατρα_δικη #π好きホイホイ

Analog memories - LOWE launch 🎞️

#rollei35
#jpm2024

Sun’s out in #SanFrancisco today, weather’s gorgeous, streets around #UnionSquare really clean, and there’s even a beautiful new French patisserie right across from the St Francis Westin. Folks, you can actually be excited to come to #JPM2024 next week. Welcome to SF!

Some important points from the Ginkgo Bioworks presentation at #JPM2024

It’s pretty simple. Nobody else has the scale of data that ginkgo has across Pharma, Ag, and industrial biotech

We had a busy week at J.P. Morgan annual healthcare event in San Francisco! As the week comes to a close, the team are delighted to have had the opportunity to meet with many industry colleagues & potential partners at the biggest healthcare conference of the year

#POLB #JPM2024

This Seismic crew is making plans for the JPM conference in San Francisco in January. Please reach out to request meetings with CEO Jo Viney PhD Jo Viney (she/her); CBO Maude Tessier PhD; CMO and Head of R&D John Sundy MD, PhD; and CRO Kevin Otipoby PhD. #WeAreSeismic #JPM2024

$CHRS #Jpm2024 slides investors.coherus.com/static-files/c…

$QURE New: BrainX™, a library of novel capsids for CNS indications (read: to be applied in future disclosed programs). Check corporate presentation with investment highlights and key milestones for 2024. Full slides: uniqure.com/assets/uploads… #JPM24 #JPM2024 #JPMorgan

$ARWR
After CEO presentation at JPM2024 we have a strong and clear strategy to commercializing,
Cardiovascular and pulmonary are core business (own sales force), maybe CNS.
Rest will be partnered.
Great stuff for sure

Great week with the best team in biotech ⁦Nimbus Therapeutics⁩ #jpm2024

🚨 TOMORROW 1/9: Don't miss the J.P. Morgan Healthcare Conference ARPA-H Fireside Chat at 7:00 AM PT! #jpm2024 #jpm24 #jpmorgan

Listen to Neurocrine’s presentation at the 42nd Annual J.P. Morgan Healthcare Conference Tuesday, January 9, at 9:45am PT. Please check here for more information: bit.ly/3S6ZBgE #JPM2024

A fun evening of connections and conversations at our annual #JPM2024 reception! 🌉

Open for a surprise!

Find the Recursion team outside the Westin for a free umbrella at #JPM2024 ☔️

#JPM2024 is here and I am excited to be in SF and meet friends, mentors, investors, and everyone who wants to learn more about cell-based #mRNA platform to unlock the next generation of mRNA medicines we are building at Sensible Biotechnologies. Let me know if you'd like to grab a coffee!

$AMAM closed at $0.41 on 12/8/22, acquired by $JNJ today for $28 or a 6,729% return is just over 1 year!

$HARP closed at $3.29 on 10/12/23, acquired by $MRK today for $23 or a 599% return in <3 months!

$XBI #JPM2024

This week, we were delighted to host GV’s healthcare founder community for breakfast, in partnership with Oak HC/FT and @hlthevent!

A special thank you to everyone who joined us during @JPMorgan’s #JPM2024 .